Language
English
Publication Date
8-27-2025
Journal
World Journal of Hepatology
DOI
10.4254/wjh.v17.i8.109801
PMID
40901593
PMCID
PMC12400317
PubMedCentral® Posted Date
8-27-2025
PubMedCentral® Full Text Version
Post-print
Abstract
Artificial intelligence (AI) has become an indispensable tool in modern health care, offering transformative potential across clinical workflows and diagnostic innovations. This review explores the sation of AI technologies in synthesizing and analyzing multimodal data to enhance efficiency and accuracy in health care delivery. Specifically, deep learning models have demonstrated remarkable capabilities in identifying seven categories of hepatobiliary disorders using ocular imaging datasets, including slit-lamp, retinal fundus, and optical coherence tomography images. Leveraging ResNet-101 neural networks, researchers have developed screening models and independent diagnostic tools, showcasing how AI can redefine diagnostic practices and improve accessibility, particularly in resource-limited settings. By examining advancements in AI-driven health care solutions, this article sheds light on both the challenges and opportunities that lie ahead in integrating such technologies into routine clinical practice.
Keywords
Artificial intelligence, Ocular biomarkers, Hepatobiliary disease, Deep learning and Kayser-Fleischer ring
Published Open-Access
yes
Recommended Citation
Parmar, Uday Pratap Singh; Morya, Arvind Kumar; Gupta, Parul C; et al., "Role of Artificial Intelligence-Based Ocular Biomarkers in Hepatobiliary Diseases: A Scoping Review" (2025). Faculty, Staff and Students Publications. 8286.
https://digitalcommons.library.tmc.edu/baylor_docs/8286